search
Back to results

Treatment of Mild and Moderate Cases of Gynaecomastia

Primary Purpose

Gynecomastia

Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
liposuction
surgical excision
Sponsored by
Sohag University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gynecomastia

Eligibility Criteria

18 Years - 60 Years (Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

- The age of patients ranges from 18-60yrs. Mild and moderate cases of gynecomastia.

Exclusion Criteria:

  • Patients with endocrine causes. Patients with genetic causes. Severe cases of gynecomastia. Patients who refused surgical intervention. Patients who are not fit for surgery. Patients with chronic illness.

Sites / Locations

  • Sohag University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

liposuction

periareolar surgical excision

Arm Description

group A will be treated with liposuction

Group B will be treated with periareolar surgical excision

Outcomes

Primary Outcome Measures

Difference between group A and B in aesthetic satisfaction
A 100 -point visual analogue scale (VAS) for the assessment of aesthetic satisfaction with 0 as the worst cosmosis and 100 as the best aesthetic result With filled standardized charts.

Secondary Outcome Measures

Full Information

First Posted
July 13, 2021
Last Updated
July 13, 2021
Sponsor
Sohag University
search

1. Study Identification

Unique Protocol Identification Number
NCT04966078
Brief Title
Treatment of Mild and Moderate Cases of Gynaecomastia
Official Title
Comparison Between Liposuction and Peri-areolar Surgical Excision in Mild and Moderate Cases of Gynaecomastia
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2021 (Actual)
Primary Completion Date
January 1, 2022 (Anticipated)
Study Completion Date
February 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sohag University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study aims to compare liposuction and periareolar surgical excision in mild and moderate cases of gynecomastia as regard cosmosis, complications, patient satisfaction, operation time, and hospital stay. This study will be carried out on patients with gynecomastia presented to the Plastic Surgery Department, Sohag University, in the period between January 2021 to January 2022 as a retrospective and prospective study. Patients will be divided into 2 groups: group A treated with suction-assisted liposuction. group B treated with peri-areolar surgical excision. Each group contains 20 patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gynecomastia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
liposuction
Arm Type
Active Comparator
Arm Description
group A will be treated with liposuction
Arm Title
periareolar surgical excision
Arm Type
Active Comparator
Arm Description
Group B will be treated with periareolar surgical excision
Intervention Type
Procedure
Intervention Name(s)
liposuction
Intervention Description
suction-assisted liposuction
Intervention Type
Procedure
Intervention Name(s)
surgical excision
Intervention Description
periareolar surgical excision
Primary Outcome Measure Information:
Title
Difference between group A and B in aesthetic satisfaction
Description
A 100 -point visual analogue scale (VAS) for the assessment of aesthetic satisfaction with 0 as the worst cosmosis and 100 as the best aesthetic result With filled standardized charts.
Time Frame
difference between group A and B in aesthetic results according to visual analogue scale at 3 month post-operative

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: - The age of patients ranges from 18-60yrs. Mild and moderate cases of gynecomastia. Exclusion Criteria: Patients with endocrine causes. Patients with genetic causes. Severe cases of gynecomastia. Patients who refused surgical intervention. Patients who are not fit for surgery. Patients with chronic illness.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gamal Y Elsaied, MD
Organizational Affiliation
sohag univeristy hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Sohag University
City
Sohag
ZIP/Postal Code
82525
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Treatment of Mild and Moderate Cases of Gynaecomastia

We'll reach out to this number within 24 hrs